Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17

Showing 17 citing articles:

Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Yujing Qian, Yujia Yin, Xiaocui Zheng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma
Shabana Habib, Gabriel Osborn, Zena Willsmore, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 895-911
Open Access | Times Cited: 10
Introducing immunology: Types of immunity, immune responses, deficiencies, and disorders
Zainab Rahman, Faheem Shehjar, Reetika Mahajan
Elsevier eBooks (2025), pp. 1-14
Closed Access
Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer
Giti Esmail Nia, Elahe Nikpayam, Molood Farrokhi, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200788-200788
Open Access | Times Cited: 3
Immunogenic cell death-based oncolytic virus therapy: a sharp sword of tumor immunotherapy
Jingyu Zhang, Jiahe Chen, Kezhi Lin
European Journal of Pharmacology (2024) Vol. 981, pp. 176913-176913
Open Access | Times Cited: 3
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 3
Tuning Cellular Metabolism for Cancer Virotherapy
Dian Xiong, Qing Wang, Weiming Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216924-216924
Closed Access | Times Cited: 2
<em>Euonymus alatus</em> (Thunb.) Siebold leaf extract enhanced immunostimulatory effects in a cyclophosphamide-induced immunosuppressed rat model
Dong-Yeop Shin, Byeong Soo Kim, Hak Yong Lee, et al.
Food & Nutrition Research (2023) Vol. 67
Open Access | Times Cited: 5
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 4
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4912-4912
Open Access | Times Cited: 4
Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis
Isabel Legáz, Elena Navarro‐Noguera, Aurelia Collados-Ros, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 336-336
Open Access | Times Cited: 1
Decorin-armed oncolytic adenovirus promotes natural killers (NKs) activation and infiltration to enhance NK therapy in CRC model
Xue Li, Yuning Zhang, Zhuang Mao, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Revolutionizing Cancer Treatment: Unleashing the Power of Combining Oncolytic Viruses with CAR-T Cells
Zhang Lin, Shuxian Guo, ShuYing Chang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1407-1418
Closed Access
溶瘤病毒助力肿瘤免疫治疗
Yujie Yang, Yian Wang, Jie Wu, et al.
Scientia Sinica Vitae (2024) Vol. 54, Iss. 11, pp. 2037-2050
Closed Access
Nature is the best designer: A novel variant of oncolytic reovirus
Raghad Khaleafi, Yotam Bar‐On
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200865-200865
Open Access
Intranasal Delivery of the Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends the Survival of Glioblastoma Bearing Mice
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top